Category: ACN Newswire

HONG KONG, July 25, 2025 - (ACN Newswire via SeaPRwire.com) - Essex Bio-Technology Limited (“Essex” or the “Group”, Stock Code: 1061.HK) is pleased to announce that (Zhuhai Essex Bio-Pharmaceutical Company Limited), an indirect wholly-owned subsidiary, has received approval from (National Medical Products Administration) for the registration and commercialisation of the multi-dose Diquafosol Sodium Eye Drops in the PRC.The Approved Product is a multi-dose eye drop formulation containing 3% diquafosol sodium (5ml:150mg), indicated for the treatment of dry eye syndromes such as conjunctival epithelium injury and tear abnormalities. The active pharmaceutical ingredient, diquafosol sodium, is a P2Y2 receptor agonist that acts on conjunctival tissues to promote the secretion of tears containing water and secretory mucins. It may also promote the expression of membrane-bound mucins on corneal epithelium. Boosting the lipid content in tears, it should quantitatively and qualitatively improve tear abnormalities and demonstrate efficacy in bringing the ocular surface condition closer to normal, and improve symptoms of dry eye and corneal epithelial damage.The Approved Product, together with the previously approved preservative-free unit-dose Diquafosol Sodium Eye Drops collectively, collectively provide more high-quality treatment options for patients in the PRC. The approval will further enrich the Group’s ophthalmic product portfolio and strengthen its market position in ophthalmology segment.About Essex (Stock Code:1061.HK)Essex is a bio-pharmaceutical company that develops, manufactures, and commercialises genetically engineered therapeutic b-bFGF, with six commercialised biologics currently marketed in China. Additionally, the Company has a diverse portfolio of commercialised preservative-free unit-dose eye drops, Shilishun (Iodized Lecithin Capsules) and others, which are principally prescribed for wound healing and diseases in Ophthalmology and Dermatology.These products are marketed and sold through approximately 14,000 hospitals, supported by the Company’s 44 regional offices in China. Leveraging its in-house R&D platform in growth factor and antibody technology, Essex maintains a robust pipeline of projects in various clinical stages, covering a wide range of fields and indications. Copyright 2025 ACN Newswire via SeaPRwire.com.

SHANGHAI, July 25, 2025 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a placing and subscription agreement with the placing agents and its controlling shareholder, CBC Group (the “Sellers”), for a top-up placement of 22,561,000 shares to raise approximately HK$1,572.50 million, representing approximately 6.87% of the total number of Shares in issue as at the date of this announcement, and approximately 6.45% of the total number of Shares in issue.Everest Medicines, together with its controlling shareholder CBC Group and the placing agents, entered into a placing and subscription agreement for the sale of 22,561,000 shares at a purchase price of HK$69.70 per share, representing:- a discount of approximately 10.12% to the closing price of HK$77.55 per share on July 24, 2025.- a discount of approximately 4.98% to the average closing price of HK$73.35 per Share as quoted on the Stock Exchange for the five consecutive trading days immediately prior to and including the Last Trading Date.- a premium of 16.15% to the volume weighted average price of HK$60.01 per Share as quoted on the Stock Exchange for the thirty consecutive trading days immediately prior to the Last Trading Date and including the Last Trading Date.The gross proceeds from the Placing and Subscription are expected to be approximately HK$1,572.50 million, and the net proceeds (after deducting all related expenses, including commission and levies) will be approximately HK$1,553.39 million.Everest Medicines intends to use approximately 50% of the net proceeds (approximately HK$776.69 million) to support global research and development of pipeline products, approximately 40% (approximately HK$621.36 million) to commercialization efforts including the launch of new products, and 10% (approximately HK$155.34 million) to working capital and general corporate purposes.“This placement was well-received by several leading international long-only funds and was significantly oversubscribed, reflecting strong capital market confidence in Everest’s commercial execution capabilities and innovative R&D strengths,” said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines. “It also underscores investors’ endorsement of our long-term strategic vision. We will use the proceeds to accelerate the development of innovative pipelines and our proprietary AI+mRNA platform, while advancing the commercialization of our existing portfolio. With a strengthened capital base, we are poised to drive both commercialization and innovation, delivering greater value to patients and shareholders.”Everest has built an industry-leading, fully integrated, and localized AI+mRNA platform, enabling the development of multiple oncology and autoimmune disease programs, including EVM14, an off-the-shelf therapeutic mRNA cancer vaccine; EVM16, a personalized mRNA cancer vaccine; and an in vivo CAR-T program aimed at building a differentiated portfolio of precision immunotherapies.- The first patient has been dosed with Everest’s internally developed personalized mRNA cancer vaccine (PCV) EVM16 at Peking University Cancer Hospital in the investigator-initiated clinical trial (IIT). Early results showed strong immunogenicity and specific T-cell responses even at a low starting dose in advanced cancer patients.- The Investigational New Drug (IND) application for EVM14, a Tumor-Associated Antigen (TAA) vaccine, has been accepted by both the National Medical Products Administration (NMPA) of China and the U.S. Food and Drug Administration (FDA), making it Everest's first mRNA cancer therapeutic vaccine to achieve dual IND submissions in both China and the United States. The first clinical batch of EVM14 was successfully released from Everest’s Jiashan manufacturing site on June 9, and is anticipated to be delivered to U.S. clinical centers by mid-August. This batch will support the clinical trials of EVM14 in both China and the United States (US).- Everest’s in vivo CAR-T program is founded upon its proprietary targeted LNP (tLNP) delivery system and has shown promising results in both humanized mouse models and non-human primates. It offers key advantages including off-the-shelf availability, lymphodepletion-free administration, and dose controllability.EVER001, a next-generation covalent reversible BTK inhibitor with global rights, is advancing through global multi-center clinical studies for glomerular diseases such as primary membranous nephropathy (pMN). Positive results from its Phase 1b/2a clinical trial demonstrated rapid onset, durable response, good tolerability, and oral convenience, offering strong potential to address unmet needs in renal disease treatment worldwide.NEFECON®, the first and only etiological treatment for IgA nephropathy (IgAN) full approved in China, the U.S., and Europe, continues to gain strong commercial traction in China following its inclusion in the National Reimbursement Drug List (NRDL), benefiting over 20,000 patients to date. Everest is also accelerating the development of its proprietary diagnostic test for Gd-IgA1 to build an integrated disease management ecosystem encompassing diagnosis, treatment, and long-term care.The New Drug Application (NDA) for Etrasimod (VELSIPITY®) has been accepted in Mainland China, with approval anticipated between late 2025 and early 2026. The NDA has also been accepted in South Korea. VELSIPITY® has been commercially launched in Macao SAR, Singapore and Hong Kong SAR in 2024. As Everest’s third commercialized product, VELSIPITY® has been officially approved by the Guangdong Provincial Medical Products Administration for adult patients with moderately to severely active UC. It is now available at medical institutions designated under the Connect Policy in the Greater Bay Area. In March 2025, Everest has launched the construction project at its Jiashan manufacturing site to support the local production for VELSIPITY®.Everest Medicines is accelerating the strategic advancement of its core pipeline and AI+mRNA technology platforms to further solidify its position as a leading innovative biopharmaceutical company in Asia.About Everest MedicinesEverest Medicines is a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that address critical unmet medical needs for patients in Asian markets. The management team of Everest Medicines has deep expertise and an extensive track record from both leading global pharmaceutical companies and local Chinese pharmaceutical companies in high-quality discovery, clinical development, regulatory affairs, CMC, business development and operations. Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company’s core therapeutic areas of renal diseases, infectious diseases and autoimmune disorders. For more information, please visit its website at www.everestmedicines.com.Forward-Looking Statements:This news release may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the Company or its officers with respect to the business operations and financial condition of the Company, which can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, or other factors, some of which are beyond the control of the Company and are unforeseeable. Therefore, the actual results may differ from those in the forward-looking statements as a result of various factors and assumptions, such as future changes and developments in our business, competitive environment, political, economic, legal and social conditions. The Company or any of its affiliates, directors, officers, advisors or representatives has no obligation and does not undertake to revise forward-looking statements to reflect new information, future events or circumstances after the date of this news release, except as required by law. Copyright 2025 ACN Newswire via SeaPRwire.com.

上海，2025年7月25日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀有限公司（HKEX1952.HK）是一家專注於創新藥研發、臨床開發、制造和商業化的生物制藥公司，今日宣布以先舊後新配售22,561,000股，集資約15.725億港元，發行股份數占現有股本約6.87%, 占經擴大後的總股數約6.43%。雲頂新耀、賣方（控股股東康橋資本）與配售代理簽訂先舊後新方式的配股協議，配售22,561,000股份，每股配售價69.70港元，較於最後交易日（即配售及認購協議日期前一天）在聯交所報所報收市價每股77.55港元折讓約10.12%，亦較於緊接最後交易日（包括該日）前連續五個交易日在聯交所所報平均收市價每股73.35港元折讓約4.98%，較於緊接最後交易日（包括該日）前連續三十個交易日在聯交所所報成交量加權平均價每股60.01港元溢價16.15 %。所得款項總額預期約為15.725億港元，而所得款項淨額（經扣除所有相關成本及開支，包括傭金及征費）將約為15.534億港元。雲頂新耀預計配售所得款項，其中50 %（約7.767億港元）用於開發自主全球研發平台及新產品管線；另外40 %（約6.214億港元）用於推進新產品商業化，包括推出新產品；及10 %（約1.553億港元）用作營業資金以及一般及行政用途。雲頂新耀首席執行官羅永慶表示，「此次配售受到多家國際長線持有基金青睞，獲得數倍超額認購，反映了資本市場對雲頂新耀商業化能力與創新研發實力的高度認可，也體現出投資者對公司長期發展戰略的充分信心。我們將充分利用此次融資所得，加快創新藥物和AI+mRNA平台的開發，同時推進現有產品的商業化進程。憑借更為充足的資本基礎，我們有信心在商業化拓展與研發創新雙線並進，不斷為患者與投資者創造更大價值。」公司已構建國際領先的、完全整合且本地化的AI+mRNA平台，重點推進腫瘤和自身免疫疾病領域的產品管線開發，包括通用型現貨腫瘤治療性疫苗EVM14、個體化腫瘤治療性疫苗EVM16，以及自體生成CAR-T項目。- 雲頂新耀自主研發的首款個性化mRNA治療性腫瘤疫苗EVM16 的IIT研究已在今年3月於北京大學腫瘤醫院順利完成首例患者給藥。該臨床試驗初步數據顯示，即使低起始劑量也能激發晚期腫瘤患者特異性T細胞反應，具有良好的免疫原性。- 通用型現貨腫瘤治療性疫苗EVM14注射液的新藥臨床試驗申請（IND）已獲中國國家藥品監督管理局和美國食品藥品監督管理局（FDA）受理，成為公司首個實現「中美雙報」的mRNA腫瘤治療性疫苗。雲頂新耀嘉善工廠已於2025年6月9日順利放行首批GMP臨床試驗樣品，該批樣品將用於支持雲頂新耀在中美兩地開展EVM14的臨床試驗。- 自體生成CAR-T項目也已在人源化小鼠與非人靈長類（猴）模型中驗證有效，具備現貨型、無需淋巴耗竭、劑量可控等優勢，展現了開發用於腫瘤及自身免疫疾病的潛力。擁有全球權益的新一代共價可逆BTK抑制劑EVER001正開展全球多中心臨床研究，主要用於治療原發性膜性腎病（pMN）等多種原發性腎小球疾病。其在原發性膜性腎病1b/2a期研究中展現出起效快、緩解持續、耐受性好、口服便捷等綜合優勢，有望為全球患者帶來更優治療選擇。耐賦康®作為首個且唯一在中國、美國和歐洲獲得完全批准的IgA腎病對因治療藥物，自納入中國國家醫保目錄以來快速放量，已惠及超過兩萬名患者。公司亦正加快推進Gd-IgA1診斷試劑的轉化，致力打造覆蓋診斷、治療、長期管理的一體化IgA腎病疾病管理生態。伊曲莫德（維適平®）在中國大陸的新藥上市申請也已獲受理，預計2025年底至2026年初獲批，其新藥上市申請也已獲韓國受理。伊曲莫德已相繼在中國澳門，新加坡和中國香港獲批，並被納入粵港澳大灣區內地9市臨床急需進口港澳藥品醫療器械目錄（2024年），已在大灣區先行使用惠及潰瘍性結腸炎患者，成為雲頂新耀第三款商業化新藥。2025年3月，雲頂新耀啟動了伊曲莫德位於嘉善工廠的生產建設項目，為伊曲莫德的本地化生產提供支持。雲頂新耀正加快推進多個核心管線及技術平台的戰略布局，進一步鞏固其在亞洲領先創新藥企中的市場地位。關於雲頂新耀雲頂新耀是一家專注於創新藥和疫苗研發、臨床開發、制造和商業化的生物制藥公司，致力於滿足亞洲市場尚未滿足的醫療需求。雲頂新耀的管理團隊在中國及全球領先制藥企業從事過高質量研發、臨床開發、藥政事務、化學制造與控制（CMC）、業務發展和商業化運營，擁有深厚的專長和豐富的經驗。雲頂新耀已打造多款疾病首創或者同類最佳的藥物組合，公司的治療領域包括腎科疾病、感染性和傳染性疾病、自身免疫性疾病。有關更多信息，請訪問公司網站：www.everestmedicines.com。前瞻性聲明本新聞稿所發布的信息中可能會包含某些前瞻性表述，乃基於本公司或管理層在做出表述時對公司業務運營情況及財務狀況的現有看法、相信、和現有預期，可能會使用"將"、"預期"、"預測"、"期望"、"打算"、"計劃"、"相信"、"預估"、"確信"及其他類似詞語進行表述。這些前瞻性表述並非對未來業績的保證，會受到風險、不確定性及其他因素的影響，有些乃超出本公司的控制範圍，難以預計。因此，受我們的業務、競爭環境、政治、經濟、法律和社會情況的未來變化及發展等各種因素及假設的影響，實際結果可能會與前瞻性表述所含資料有較大差別。本公司及各附屬公司、各位董事、管理人員、顧問及代理未曾且概不承擔更新該稿件所載前瞻性表述以反映在本新聞稿發布日後最新信息、未來項目或情形的任何義務，除非法律要求。 Copyright 2025 亞太商訊 via SeaPRwire.com.

香港，2025年7月25日 - (亞太商訊 via SeaPRwire.com) - 隨著粵港澳大灣區建設不斷深化，區域內居民對跨境醫療服務與醫療保險協同發展的需求日益迫切。7月24日，一場以"粵港澳大灣區醫療保險發展"為主題的行業論壇於香港舉行，來自保險、醫療、科技等領域的機構代表與專家齊聚一堂，圍繞跨境醫療保障一體化、保險產品創新與服務標準化等核心議題展開深入交流。論壇期間，各方共同探討大灣區醫療保險發展新路徑，並見證跨境醫療行業解決方案正式發佈。聚焦醫療互聯互通，發佈跨境保障方案論壇上，鎂信健康創始人兼首席執行官張小棟先生指出，粵港澳大灣區作為我國經濟最具活力的區域之一，在國家發展大局中具有重要戰略地位。"塑造健康灣區"戰略的踐行，是對千萬灣區居民"病有所醫、醫有所保"期盼的回應。鎂信健康圍繞"藥品可及、醫療連接、支付簡化"三個核心痛點，推出跨境醫療解決方案，具體涵蓋：第一件事，是"把藥帶進來"。依託鎂信創新藥械的資源優勢，致力於把最新上市的癌症、罕見病治療藥、以及海南特藥特械等全球創新藥械帶到大灣區患者的身邊；第二件事，是"把醫連起來"。提供包括專家預約、陪診、第二診療意見、住院手術安排等全流程服務，優化港人北上診療體驗；第三件事，是"把支付變簡單"。依託鎂信的一碼直付平臺，探索實現患者北上就醫無需墊付，努力讓跨境醫療的保險理賠像掃碼一樣簡單。鎂信健康創始人兼首席執行官 張小棟在跨境醫療解決方案環節，中再壽險產品開發部總經理王明彥先生與鎂信健康首席商務官郎立良先生也分別發表主題演講。他們深入探討了跨境醫療在大灣區面臨的機遇與挑戰，分享了在產品設計、服務模式等方面的創新實踐與經驗。匯聚行業智慧 共建健康灣區活動現場同步舉行「服務國家戰略，共建健康灣區」發佈儀式，宣佈各方將在資源整合，模式創新等層面持續合作，探索更多適配於大灣區的醫療保險產品與服務。在隨後的圓桌論壇環節，由鎂信健康首席商務官郎立良先生擔任主持人，與尚志醫療集團醫務行政總監、外科專科醫生郭寶賢先生，中國太平洋人壽（香港）聯席行政總裁、香港精算學會（ASHK）前主席、現任理事Simon Lam先生，香港精算視覺保險學會會長、大灣區保險學院聯合創始人牟劍群先生，以及諾華香港的相關代表深入探討大灣區醫療保融合的各方實踐。各位嘉賓從不同角度分享了對大灣區醫療保險發展的見解與建議，探討了如何加強大灣區醫療保障合作、提升醫療服務水準、促進保險產品創新等關鍵問題。鎂信健康在論壇中積極發聲，提出通過公立+特需/私立結合、資源整合等方式，賦能醫療資源的互補和互通，推動大灣區醫療保險服務的升級與優化，為大灣區居民提供更加優質的醫療保障體驗，得到了與會嘉賓的廣泛認可與支持。「服務國家戰略，共建健康灣區」發佈儀式凝聚信心 攜手同行論壇壓軸環節，中國太平洋人壽保險原董事長、大家保險集團原總經理徐敬惠先生發表主旨發言。他從行業發展的宏觀角度，對大灣區醫療保險的未來發展進行了深入分析與展望，總結出三個"心"的感受。首先是信心，近年來，在各項政策的推動下，大灣區醫療互聯互通成效明顯，多項跨境醫療福利成功"過河"，跨境醫療的"民生流量"也在政策協同的推動下持續升溫，這讓我們對未來充滿信心。第二個是"初心"，徐敬惠先生強調，"以人民健康為中心"的初心，是破解難題的指南針。最後是"同心"，不管是中再、鎂信，還是醫療、醫藥機構，都在各自領域搭建著連通橋，各方攜手共同推動大灣區醫療保險事業的發展，為大灣區居民的健康保駕護航。此次論壇發佈的"灣區跨境醫療解決方案"，鎂信健康深度參與並提供特藥支持。它打破了地域壁壘，整合了兩地資源，為跨境醫療服務的標準化、一體化樹立了典範。這種合作模式不僅提升了居民的健康保障體驗，也為行業探索出了一條可持續發展的新路。本次粵港澳大灣區醫療保險發展論壇的順利舉行，不僅推動了灣區保險行業對跨境醫療議題的深度關注，也為後續創新與產業協作奠定了良好基礎。鎂信健康作爲參與方之一，將持續深耕大灣區，攜手更多夥伴推進醫療保障數智化轉型，助力實現健康灣區的美好願景。 Copyright 2025 亞太商訊 via SeaPRwire.com.

SAN DIEGO, July 24, 2025 - (ACN Newswire via SeaPRwire.com) - International Land Alliance, Inc. (OTCQB: ILAL) (“ILAL” or the “Company”), a global real estate investment and development firm, today announced the launch of a new product offering at its flagship Cabo Oasis and Valle Divino developments in Baja California. With a focus on sustainable design and affordability, this initiative marks a significant expansion of the Company’s master-planned communities.International Land Alliance has identified initial locations within its 500-acre Cabo Oasis beachfront development to introduce Tesla-powered tiny homes. These units are designed to serve as vacation, second, or retirement residences—offered at a purchase price of under $100,000 or a lease option for under $1,000 per month.“We are bringing sustainable, high-quality living to everyone at a price that was once unimaginable,” said Frank Ingrande, President & CEO. “These homes emphasize eco-friendly design, compact efficiency, and cutting-edge technology, all while helping solve the affordability crisis that’s impacting many, especially in California.”As part of our broader vision to expand Cabo Oasis, ILAL is developing separate private neighborhoods within the master-planned community to accommodate a wide variety of homeownership needs and budgets—including condominiums, private estates, and these new tiny home options.The Company is currently in discussions with a leading tiny home manufacturer and expects to receive its first Tesla-powered model at Cabo Oasis within the next 30 days. The name of the provider will be announced shortly thereafter.The tiny homes will be available in both stationary and mobile versions, enabling owners to relocate between ILAL’s growing portfolio of communities across Baja California.Key Features of the Cabo Oasis Tiny Homes:Solar-Powered Everything – Integrated Tesla Solar Roof panels and a Powerwall battery ensure energy independence making this 100% off-grid capable.Smart Home Integration – Includes full home automation for lighting, climate, and security controls.Sleek, Futuristic Design – Modular interiors that maximize space and feature premium finishes.Zero Utility Costs – Energy-efficient systems designed to eliminate traditional energy bills.About Cabo OasisCabo Oasis is International Land Alliance’s flagship beachfront community in Baja California, featuring 500 acres of master-planned development with ocean views, resort amenities, and a wide range of residential options designed for sustainable coastal living.About Valle DivinoLocated in the heart of Baja’s wine country, Valle Divino is a luxury vineyard community that offers scenic living amidst Ensenada’s world-renowned wine region. The project blends boutique vineyard living with modern sustainability.About International Land Alliance, Inc.International Land Alliance, Inc. (OTCQB: ILAL) is a publicly traded real estate development company focused on acquiring desirable land and real estate assets in Northern Baja California and Southern California. With a mission to provide accessible housing solutions through innovative design and technology, ILAL builds environmentally friendly communities for vacation, retirement, and investment buyers.International Land Alliance, Inc. (OTCQB: ILAL) is an international land investment and development firm based in San Diego, California. As its’ core mission, the Company has embraced technology for sustainable and socially responsible solutions, in addition to using proptech and construction tech advanced applications to meet these goals. The Company is focused on acquiring attractive raw land primarily in Northern Baja California, often within driving distance from Southern California. The Company serves its shareholders by devoting considerable time and resources to seeking out the finest sites available and obtaining the necessary development permits to build a compelling portfolio of properties, which provide a diversity of investment and living options. Please visit: www.ila.company.For media inquiries, contact:Investor Relationsinfo@ila.company(877) 661-4811www.ila.company Safe Harbor StatementThe press release may include certain statements that are not descriptions of historical facts but are forward looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements may include the description of our plans and objectives for future operations, assumptions underlying such plans and objectives, and other forward-looking terminology such as "may," "expects," "believes," "anticipates," "intends," "projects,” or similar terms, variations of such terms or the negative of such terms. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements made herein. Such information is based upon various assumptions made by, and expectations of, our management that were reasonable when made but may prove to be incorrect. All such assumptions are inherently subject to significant economic and competitive uncertainties and contingencies beyond our control and upon assumptions with respect to the future business decisions which are subject to change. Accordingly, there can be no assurance that actual results will meet expectations and actual results may vary (perhaps materially) from certain of the results anticipated herein. Copyright 2025 ACN Newswire via SeaPRwire.com.

- The implementation of streamlined approval procedures for Hong Kong- and Macao-registered proprietary Chinese medicines (“pCms”) by mainland China presents significant opportunities for Hong Kong companies to expand into the Greater Bay Area and other mainland market.- A unified and comprehensive registration system strengthens the quality control of Hong Kong's pCms, reinforcing confidence among other regulatory bodies and stakeholders.- Hong Kong's first Chinese medicine hospital will gradually commence operations by year end. This will help promote the popularity of Chinese medicine and pCms.HONG KONG, July 24, 2025 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Trade Development Council (“HKTDC”) today released a report, "Challenges and Opportunities in Hong Kong's Proprietary Chinese Medicine Industry," that analyses the sector’s development, challenges, and export potential of Hong Kong’s pCm sector. With the completion of the transitional registration process for pCms in June this year, all pCms sold in Hong Kong now hold formal registration, marking a new era in the regulatory regime. The Chinese Medicine Hospital of Hong Kong is set to begin operations by late 2025 further popularising pCms. Additionally, mainland China has streamlined approval procedures for Hong Kong-registered traditional pCms, creating easier access to the mainland market.Hong Kong’s pCms enjoy a strong reputation, with streamlined registration procedures facilitating expansion into the Mainland marketHong Kong currently has approximately 2,000 companies involved in pCms and Chinese herbal medicine-related businesses, including import/export trade, manufacturing, wholesale and retail. Among these, some 264 enterprises are listed as local pCm manufacturers. The majority of pCms produced in Hong Kong are geared toward the consumer market. In 2024, Hong Kong’s pCm exports totaled HK$2.88 billion with 93% locally produced, setting the industry apart from re-export-driven sectors. Mainland China remains the largest export market, accounting for over 70% of exports, followed by Macao (20%), and ASEAN (6%).Wing Chu, Principal Economist (Greater China) of the HKTDC, stated: "Many Hong Kong proprietary Chinese medicines companies are eager to expand exports especially to the mainland market although pCm imports in mainland China are relatively small, with different pCms registration system and technical standards from those of Hong Kong. Notably, Hong Kong’s pCms are highly regarded in Southern China and overseas Chinese communities, and streamlined approval procedures in mainland China for traditional pCms of Hong Kong and Macao offer significant opportunities for Hong Kong businesses to expand into the Greater Bay Area and other mainland markets. Additionally, the rise of online shopping enables companies to leverage cross-border e-commerce platforms to access mainland and overseas markets, provided they comply with the corresponding regulatory requirements.”Comprehensive registration system drives standardisation of Chinese medicineThe report indicates that, in recent years, the HKSAR Government has actively promoted the development of Chinese medicine. Key initiatives include the establishment of the Chinese Medicine Council of Hong Kong to oversee the registration and management of pCms, and continuous support for Chinese medicine services in areas such as education, medical treatment, and scientific research. These efforts have enabled Hong Kong to cultivate professional Chinese medicine talent and promote the modernisation of Chinese medicine. Earlier this month, some 345 Hong Kong enterprises, including traders, registered a total of 8,244 pCms.The report states that a unified and comprehensive registration system enhances the quality control of Hong Kong's pCms, further increasing the confidence of other regulatory bodies and stakeholders in these products. Hong Kong's first Chinese medicine hospital is set to open in late 2025, providing comprehensive diagnostic and treatment services with Chinese medicine, which will drive the popularisation of Chinese medicine and pCms.In addition, Hong Kong pCm companies and local universities are committed to developing new pCms to further expand the market. Recently, the Centre for Chinese Herbal Medicine Drug Development at Hong Kong Baptist University (HKBU), funded by the Innovation and Technology Commission of HKSAR Government under the InnoHK Research Clusters, developed a novel drug, CDD-2101, for the treatment of chronic constipation. The innovation is based on previous pilot clinical studies and basic research on the traditional Chinese herbal formulation "MaZiRenWan”. For the first time, it has received authorisation for clinical research in the United States.Prof. BIAN Zhaoxiang, Director of the Centre for Chinese Herbal Medicine Drug Development and Associate Vice-President (Clinical Chinese Medicine) at HKBU, said: "Our goal is to collect sufficient safety and efficacy data to obtain FDA approval for CDD-2101 as a marketable new drug and successfully launch it in the United States. This represents not only a major breakthrough in the research and development of Chinese medicine in Hong Kong but also an important step in driving the standardisation and internationalisation of Chinese medicine.”Mainland market surpasses RMB450 billionMainland China, the world's largest pCm market valued at RMB450 billion, streamlined registration and approval procedures in 2021 for traditional pCms for external use being sold in Hong Kong and Macao. In January 2025, the National Medical Products Administration further simplified the approval process for traditional pCms for oral use, provided they have been in use in Hong Kong for more than 15 years and whose production processes comply with Good Manufacturing Practice (GMP) requirements. Relevant application materials and technical requirements were also released in April this year. The report notes that the implementation of the streamlined registration procedures opens a more convenient channel for Hong Kong companies to expand into the Greater Bay Area and other mainland markets.The recognition and acceptance of pCms differ across overseas regions. In many international markets, pCms are categorised and regulated as herbal medicines, health foods or dietary supplements. However, many Southeast Asian countries have specific, similar legal requirements for pCms, providing a clear pathway to enter these markets.The rapid growth of global e-commerce has created new sales channels for Hong Kong’s pCms through cross-border e-retail. For the mainland market, the report points out that certain pCms for external use, such as Chinese medicinal wines and cooling oils, have been incorporated in the Cross-border E-commerce Retail Import Commodity List, allowing relevant products to be sold to mainland China through cross-border e-commerce channels.In overseas markets, the e-commerce retail sector in ASEAN is experiencing significant growth, fueled by robust demand for herbal and health-related products in local markets. By adhering to local regulations, Hong Kong pCm enterprises can capitalise on additional business opportunities through online channels.Annual Chinese Medicine Conference to Share Latest Research FindingsTo foster the development of the Chinese medicine industry, the International Conference of the Modernization of Chinese Medicine & Health Products will be held at the Hong Kong Convention and Exhibition Centre from 15 to 16 August 2025. The conference is jointly organised by the Modernized Chinese Medicine International Association, the HKTDC and 10 scientific research institutions. During the event, 21 scholars and experts from medical schools, research institutions, pharmaceutical companies and organisations from mainland China, Hong Kong, Malaysia and Thailand will discuss the latest research progress in the prevention and treatment of tumors, inflammation, and cardiovascular and cerebrovascular diseases using traditional medicine. They will also present a number of related clinical research results and share successful cases. For more details, please visit: https://www.hktdc.com/event/icmcm/en.Report and photo download: https://bit.ly/45kCaXuThe HKTDC today released its research report, "Challenges and Opportunities in Hong Kong's Proprietary Chinese Medicine Industry." Pictured from left are Wing Chu, Principal Economist (Greater China Research Team) at the HKTDC, and Prof. Bian Zhaoxiang, Director of the Centre for Chinese Herbal Medicine Drug Development at Hong Kong Baptist UniversityWing Chu, Principal Economist (Greater China Research Team) at the HKTDC, pointed out that mainland China has streamlined the approval procedures for eligible traditional proprietary Chinese medicines from Hong Kong and Macao, providing more opportunities for Hong Kong businesses to expand into the Greater Bay Area and mainland marketsProf. Bian Zhaoxiang, Director of the Centre for Chinese Herbal Medicine Drug Development at HKBU, stated that the university’s earlier development of a novel drug for chronic constipation is based on an ancient Chinese herbal formulation and was authorised for clinical research in the United States for the first time. This marked an important step in driving the standardisation and internationalisation of Chinese medicineMedia EnquiriesOgilvy Public RelationsChole ChanTel: (852) 6809 6633Email: chloe.chan@ogilvy.comLeanne PokTel: (852) 9379 9694Email: leanne.pok@ogilvy.comHKTDC's Communications and Public Affairs DepartmentStanley SoTel: (852) 2584 4049Email: stanley.hp.so@hktdc.orgSerena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgMedia Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, July 24, 2025 - (ACN Newswire via SeaPRwire.com) - Quantum Solutions Co.,Ltd. (2338.T), a Tokyo Stock Exchange-listed company, announced the official launch of its Bitcoin treasury initiative in 23rd July. Over the next 12 months, the company plans to gradually build a reserve position of up to 3,000 Bitcoins (BTC) as part of a broader long-term strategy to diversify its corporate treasury assets. The initiative will be managed and executed by its wholly owned Hong Kong subsidiary, GPT Pals Studio Limited, and will begin with an initial investment of USD 10 million provided by international investment firm Integrated Asset Management (Asia) Limited.This marks Quantum Solutions’ first public move into digital asset allocation. The company views Bitcoin as a long-term, strategic reserve instrument and will implement the plan in phases to ensure proper risk control and financial governance. The 3,000-BTC target will be pursued in stages, with procurement timing and scale subject to prevailing market conditions, capital availability, and regulatory context.Integrated Asset Management (Asia) is a Hong Kong-based investment company that led the acquisition of Forbes Media in 2014. The firm, founded by Tak Cheung Yam, specializes in public and private equity investments. Mr. Yam, through its controlled entities, including Integrated Asset Management (Asia), is a major shareholder of Forbes Media, with the Forbes family retaining a minority stake. Integrated Asset Management’s engagement in this initiative underscores a growing institutional openness toward incorporating Bitcoin within modern corporate treasury considerations.The operational responsibility for the Bitcoin reserve project lies with GPT Pals Studio Limited, which has begun establishing a secure and auditable digital asset infrastructure, including segregated cold and hot wallet systems, internal controls, and accounting mechanisms. The company’s board and audit committee will provide periodic oversight of the portfolio’s valuation, exposure, and governance, in accordance with applicable regulatory and accounting standards.At current market prices, the target reserve of 3,000 BTC would be equivalent to approximately JPY 53.8 billion (USD 350 million). The company clarified that this is a long-term positioning effort rather than a short-term speculative activity and that it intends to align asset deployment with financial stability and shareholder value.“We are uniquely positioned to build a Bitcoin-first capital structure. Our goal is not only to accumulate Bitcoin, but to do so with institutional-grade discipline,” said Francis Zhou, CEO of Quantum Solutions. “We are in advanced discussions with top-tier asset managers, sovereign wealth allocators, and fintech leaders to scale our treasury roadmap responsibly and rapidly.”Globally, an increasing number of public companies and institutional investors are adopting Bitcoin as a hedge against inflation and monetary policy risk. Quantum Solutions’ initiative places it among a growing group of companies taking early steps toward integrating blockchain-based assets into their financial frameworks. The decision to leverage Hong Kong as the operational base reflects confidence in the region’s infrastructure, policy clarity, and gateway role for global capital engagement.Tak Cheung Yam, founder of Integrated Asset Management Limited, shared his perspective on Quantum Solutions: "Quantum Solutions demonstrates a clear strategic vision and determination. I see compelling potential in their approach to building a significant Bitcoin treasury, and I look forward to supporting their efforts in unlocking institutional pathways and capital alignment. It's a timely opportunity for firms with global ambition and focused execution."This launch represents a significant development in Quantum Solutions’ broader capital strategy, transitioning from a traditional AI and tech solutions provider to an enterprise with a forward-looking, diversified financial architecture. The company will continue to explore ways to enhance its treasury structure by evaluating new asset classes and cross-border capital tools that strengthen its long-term balance sheet resilience.If the Bitcoin reserve program generates a material impact on the company’s financial performance in the future, disclosures will be made in accordance with Tokyo Stock Exchange regulations and financial reporting requirements.About Quantum Solutions Co., Ltd.Quantum Solutions Co., Ltd. (Tokyo Stock Exchange: 2338.T) is a Tokyo-based high-growth technology company specializing in artificial intelligence, big data analytics, and blockchain-related innovation. Founded in 2004 and listed on the Tokyo Stock Exchange, the company delivers advanced technology solutions across a range of industries, including fintech, healthcare, and smart manufacturing. In its financial year ended 28 February 2025, Quantum Solutions reported approximately USD 4.7 million in revenue and is currently holdings over several trademarks and patents in games. For more information, please visit: https://www.quantum-s.co.jp/en/corporate Forward-Looking StatementsThis press release contains forward-looking statements based on information currently available to the company and certain assumptions regarding future events and expectations. These statements are subject to various risks and uncertainties—including but not limited to changes in policy, market conditions, technological developments, and regulatory factors—that could cause actual results to differ materially from those expressed or implied in such statements. Existing and prospective investors are advised to consider potential risks carefully and not to place undue reliance on any forward-looking statements contained herein. Such statements speak only as of the date of this release. Unless required by law, the company undertakes no obligation to update or revise any forward-looking statements in light of new information, future events, or other circumstances.For further enquiries, please contact:Hong Kong/International:Mr. Steven TungEmail: steven.tung@quantum-s.co.jpJapan:Ms. Linda PengEmail: linda.peng@quantum-s.co.jp Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年7月24日 - (亞太商訊 via SeaPRwire.com) - 日本東京證券交易所掛牌企業 Quantum Solutions Co.,Ltd.（2338.T）於7月23日宣佈，正式啟動比特幣儲備業務，計劃在未來12個月內逐步建立最多3,000枚比特幣（BTC）的儲備倉位，作為其長期財務戰略中的數字資產配置項目。該計劃將由集團全資擁有的香港子公司 GPT Pals Studio Limited 負責執行，初期建設所需的資金已獲國際私募投資機構 Integrated Asset Management (Asia) Limited 提供，金額為1,000萬美元。這是Quantum Solutions首次在公開層面披露其對加密資產的部署計劃。公告顯示，該公司將比特幣視為未來企業資產結構中的長線「戰略型儲備品種」， 計劃將分階段實施，以確保其得到適當風險管控和財務管治。3,000枚比特幣（BTC）計劃將採取階段化路徑實施，購入時機和規模取決於現行市場條件、資本可用性和監管環境。Integrated Asset Management (Asia)是一家總部位於香港的投資公司，於 2014 年主導了對福布斯傳媒的收購。該公司由任德章先生創立，專注於公募和私募股權投資。任先生透過其控股公司，包括Integrated Asset Management (Asia) 持有福布斯傳媒的多數股權，餘下少數股權則由福布斯家族持有。Integrated Asset Management (Asia)參與這項計畫突顯了機構投资者對將比特幣納入現代企業的財務考量之開放程度日益提高。根據披露，該比特幣儲備項目將由GPT Pals Studio Limited具體承擔相關建設與運維工作，公司已開始建立安全且可審計的數位資產基礎設施,包括專屬數字資產冷熱錢包隔離系統、内部風險控制和會計機制，等基礎工作。公司的董事會及審計委員會將根據適用的監管和會計標準，定期監督投資組合的估值、風險敞口和管治。根據當前市場價格測算，3,000枚比特幣的總價值約為538億日元（折合約25億港元），公司表示，這是一項長期的投資策略，而非短期投機，並表示其資產配置將以財務穩定性與股東價值為導向。Quantum Solutions 執行長（Francis Zhou）表示：「我們具備獨特優勢，可打造以比特幣為核心的資本架構。我們的目標不僅是累積比特幣，更要以機構級的紀律執行此目標。」「我們正與頂尖的資產管理公司、主權財富管理機構以及金融科技領袖進行高層次的磋商，以負責且迅速的方式擴展我們的財務規劃藍圖。」當前，全球愈來愈多國際上市企業與大型機構投資者已將比特幣納入財務結構之中，用以對沖通脹及分散貨幣政策風險。Quantum Solutions 此次計劃的推出，正處於該趨勢的早期階段。公司本次選擇以香港作為數字資產業務的運營中心，也反映出其對區域金融制度、基礎設施與監管環境的信心。Integrated Asset Management Limited創辦人任德章表示：「Quantum Solutions 展現出明確的策略願景與堅定的決心。我認為他們在打造具規模的比特幣財庫方面有潛力引人注目，我期待支持他们在開拓機構通道及資本協調的努力。對於具備- 全球拓展雄心與專注執行力的企業而言，這是一個恰逢其時的良機。」該計劃的啟動，亦可視為Quantum Solutions從傳統科技解決方案企業向多元化財務體系構建方向邁出的關鍵一步。配合未來業務增長，公司將在資本結構層面持續評估新型資產工具與技術平臺的整合可能性，以提升綜合財務穩健性與全球應對能力。據悉，若本次比特幣儲備業務在未來對財務報表構成實質性影響，公司將依據東京交易所相關規定進行必要的信息披露與更新。關於 Quantum SolutionsQuantum Solutions Co.,Ltd.（東京證券交易所：2338.T）是一家總部位於日本東京的高成長科技企業，專注於人工智能、大數據分析及區塊鏈相關技術的研發與應用。公司成立於2004年，並于東京證券交易所掛牌上市。Quantum Solutions 的核心業務涵蓋金融科技、醫療健康、智能製造等多個行業領域，致力於以技術驅動產業轉型。截至 2025 年 2 月 28 日，公司實現收入約470 万美元，擁有数項游戏类别的注册商标和技術專利。更多信息請訪問公司官網：https://www.quantum-s.co.jp/en/corporate前瞻性聲明本新聞稿包含根據公司目前可取得之資訊，以及對未來事件與預期所作的若干假設所形成的前瞻性聲明。此類聲明涉及各種風險與不確定性，包括但不限於政策變動、市場狀況、技術發展及監管因素，皆可能導致實際結果與此類聲明中所表達或暗示的結果出現重大差異。建議現有及潛在投資者審慎評估潛在風險，並避免對本新聞稿中所包含的任何前瞻性聲明寄予過高信賴。此類聲明僅適用於本新聞稿發佈之日，除法律另有規定外，公司並無義務因新資訊、未來事件或其他情況而更新或修正任何前瞻性聲明。如有進一步查詢，請聯絡：香港/國際：Mr. Steven TungEmail: steven.tung@quantum-s.co.jp日本：Ms. Linda PengEmail: linda.peng@quantum-s.co.jp Copyright 2025 亞太商訊 via SeaPRwire.com.

DUBAI, July 21, 2025 - (ACN Newswire via SeaPRwire.com) - 31 Concept (31C), a technology startup specializing in advanced network intelligence and traffic visibility solutions, today officially announces its emergence from stealth mode. Following a successful $6 million pre-seed funding round in December 2024, the company has grown to a team of 35 world-class professionals and quietly achieved several critical milestones, including the development of its flagship platform designed to enhance digital sovereignty, cyber defense, and national infrastructure visibility.31 Concept Next-Gen Network IntelligenceOver the past several months, 31C has operated in stealth while building a groundbreaking platform that enables real-time inspection and classification of network traffic - even when encrypted. This advanced solution is engineered to help governments, regulators, law enforcement agencies, and large enterprises gain deep visibility into digital communications and infrastructure activity. It combines high-performance packet-level analytics with AI-driven intelligence.At the ISS Asia 2025 Conference, taking place the first week of September in Singapore, 31 Concept will publicly debut its platform for the first time in a closed-door session dedicated to government, regulatory, and law enforcement audiences. This presentation will include a live demonstration, showcasing how 31C's technology provides deep, actionable insights critical for national and digital security."We've spent the past year building in silence, and now we're ready to show the world what we've been working on," said Misha Hanin, CEO of 31 Concept. "Our mission is to enable the guardians of digital infrastructure to reclaim visibility and control-especially in a world dominated by encryption, fragmentation, and geopolitical uncertainty."The $6 million in initial funding (Pre-seed) came from a mature strategic investor who shared the company's vision and long-term approach to innovation. Since then, 31C has successfully delivered multiple technical and business milestones, validating the platform's real-world applicability.Pioneering Research Through 31C Research DivisionAt the core of 31C's long-term innovation strategy lies its dedicated research division - 31C Research. This division operates at the intersection of science and technology, bringing together a global team of PhDs in quantum cryptography, professors in mathematics, and hands-on experts in cybersecurity, networking, and artificial intelligence.Unlike traditional R&D teams, 31C Research isn't just focused on product development; it is tasked with pushing the boundaries of what's possible in intelligent traffic analysis, encrypted data interpretation, and quantum-resistant security frameworks. The division is already contributing to advanced studies in post-quantum cryptography, secure communications, and AI-augmented traffic inspection.In line with the company's commitment to give back to the global tech community, 31C Research will also begin open-sourcing selected internal tools and research assets on GitHub, supporting collaboration, transparency, and educational initiatives across the cybersecurity ecosystem."Our research arm reflects our belief that fundamental breakthroughs come when rigorous science meets real-world urgency," said Boriss Heismann, CTO of 31C. "We're not just building for now-we're building for the next era of cybersecurity and digital defense."Contact InformationMisha HaninCEOmisha.hanin@31c.ioSOURCE: 31 Concept Copyright 2025 ACN Newswire via SeaPRwire.com.

Over 100 attendees gathered at Suntec Singapore Convention & Exhibition Centre forONERHT Foundation’s 8th GAIL Forum 2025Forum featured high-level discussions on a wide range of topics including green leadership,ESG regulatory frameworks, carbon markets as well as the role of artificial intelligence (AI) inadvancing a sustainable futureSINGAPORE, July 24, 2025 - (ACN Newswire via SeaPRwire.com) - ONERHT Foundation Ltd (“Foundation”), the corporate social responsibility vehicle of RHTLaw Asia LLP and the RHT Group of Companies (collectively, “ONERHT”), successfully concluded its 8th edition of Greening ASEAN: Initiatives & Leadership (GAIL) Forum which was held on 22 July 2025 at Suntec Singapore Convention & Exhibition Centre.Photo by Ministry of Culture, Community and Youth (MCCY)The forum, themed “Industry, Business, and Regulatory Perspectives on Climate Mitigation and Adaptation,” welcomed over 100 participants, and featured a focused half-day programme of discussions and knowledge exchange.Ms.Low Yen Ling, Senior Minister of State, Ministry of Culture, Community and Youth & Ministry of Trade and Industry graced the event as Guest-of-Honour, delivering a keynote address.Ms.Kaylee Kwok, Chairman of ONERHT Foundation, said, “At GAIL 2025, we saw a powerful convergence of actionable insights and strategies from business and industry leaders as well as sustainability domain experts. These dialogues reflect the Foundation’s commitment in facilitating meaningful conversations that help shape ASEAN’s sustainable development journey.”The programme featured a dynamic fireside chat on “The Future of Green Leadership in ASEAN – How Businesses and Professional Services Can Drive Impact,” which explored real-world case studies on leadership models which aimed to drive sustainability agendas in corporate and professional spheres.A presentation on “Navigating ASEAN’s Green Transition: Legal and Policy Pathways” provided delegates with a comprehensive update on ASEAN’s progress in carbon markets under the Paris Agreement, key developments in ASEAN’s transition and disclosure frameworks, the evolution of corporate responsibility in the context of directors’ duties and climate justice in ASEAN.The session on “Developing and Investing in Carbon Markets in Asia: Business and Regulatory Perspectives” explored the current state of carbon markets in the region, investment opportunities and financial mechanisms, as well as the evolving legal frameworks, standards, and methodologies shaping carbon trading across Asia.Ms.Ch’ng Li-Ling, Director of RHT GRACE Institute, said, “Embedding sustainability into core governance, risk and compliance frameworks is essential. Our conversations today demonstrate that ESG is now foundational for the long-term success of any business.”Since its 2018 launch, the ONERHT Foundation GAIL Forum has grown as a central platform for catalysing sustainable development across ASEAN. With the Foundation marking its 10th anniversary this year, GAIL continues to reinforce cross-sector collaboration, capacity-building, and sustainability leadership in the region. To date, ONERHT Foundation has raised more than S$5.5 million to support over 35 charitable organisations.ONERHT Foundation LtdA Singapore registered charity and grant-making philanthropic organisation, ONERHT Foundation Ltd (“Foundation”) enables RHTLaw Asia LLP and the RHT Group of Companies (collectively, “ONERHT”) to do right and do good through various charitable endeavours. Set up by ONERHT in 2015, the Foundation was registered as a Singapore charity by the Commissioner of Charities and a grant-making philanthropic organisation by the Inland Revenue Authority of Singapore on 16 September 2016 and 28 November 2016 respectively. The Foundation seeks to establish, inspire and encourage the right philanthropic culture among the corporate and legal fraternity of giving back to the community in a focused, hands-on and meaningful manner. Since its inception, the Foundation has raised more than S$5.5 million to support more than 35 beneficiaries involved in education, the environment protection and sustainability, disadvantaged groups as well as the arts and sports.For more information, please visit www.onerht.foundationRHT GRACE Institute LtdRHT GRACE Institute (“RGI”) is a social enterprise launched by ONERHT Foundation Ltd in 2020. RGI seeks to establish a culture and creed of raising consciousness, encouraging ethical leadership, and growing a community of values-aligned mindfully ethical leaders, professionals, and businesses. The mission of RGI is anchored on the core principles based on Governance, Risk, AML, Compliance & ESG (G.R.A.C.E.) within an organisation’s business model, infusing these into its culture, and influencing and impacting leaders, professionals and individuals by setting a precedent and standard for what is expected in decision making and behaviour. The vision of RGI elevates an organization from good to great, embedding its principles in members’ business models, organizational strategy and decision-making processes and influencing them to become custodians and champions of G.R.A.C.E. principles.RGI runs the podcast “EthBeats: Lessons in G.R.A.C.E.ful Living”.For media enquiries, please contact:Melody Ong Email: melody@waterbrooks.com.sg +65 8901 9780General enquiriesEmail: query@waterbrooks.com.sg +65 9338 8166 Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年7月24日 - (亞太商訊 via SeaPRwire.com) - 近日，中國領先的農產品B2B數字化服務公司一畝田集團向美國證券交易委員會（SEC）遞交招股書，申請在納斯達克上市，股票代碼擬定為「YMT」，發行價區間為每股4.10美元至5.00美元，擬募資約2000萬美元。目前一畝田董事長鄧錦宏已帶領團隊在美國展開路演，向全球投資者展示其獨特的商業模式和對中國農業的深遠影響，並預計於7月底完成上市。一畝田成立於2011年，從最初信息服務平台成長為目前覆蓋農業全產業鏈的綜合性數字農業企業，累計服務超5600萬用戶，獲紅杉中國、雲鋒基金、DST等頂級機構投資，是中國農業互聯網的領軍企業。招股書顯示，按2024年收入和月活躍商家數量計算，一畝田是中國大陸最大的農業B2B平台。其中一畝田APP數字平台是公司基礎業務，以互聯網平台進行農產品B2B產銷對接，主要用戶為產地農產品經紀人及銷地批發商、商超、電商等各類大宗農產品買家。農產品經紀人是一畝田平台的主要服務群體，這和中國農業的國情密不可分。中國農業以小規模家庭農場為主，98%以上的農戶經營全國70%以上的土地，人均耕地僅0.5英畝，導致生產分散、產品非標準化，需經紀人連接農戶與買家，扮演「找貨」、「做貨」的服務角色。一畝田為這些經紀人提供廣告、認證等服務，並收取一定費用，幫助他們對接農產品採購商。過去14年時間，一畝田已經在中國農產品經紀人中間形成了廣泛的市場影響力，並獲得穩定的商業收入，公司於2024年錄得收入1.6億元人民幣。根據弗若斯特沙利文報告，2024年，中國初級農產品流通總價值達到5.5萬億元人民幣，具有廣闊的市場。隨著中國電商、團購等新消費方式的興起，越來越多的經紀人開始進入產地直接採購，農產品經紀業務的市場前景廣闊。2024年，為滿足新興買家群體對專業、規範經紀業務的需求，一畝田開啟「沃來采」線下門店建設，依託平台14年積累的買家渠道及行情數據，用數字化、互聯網及人工智能工具，重新梳理設計更加規範、高效的農產品經紀服務流程和規則，為買家提供覆蓋全國的貨源供給、及時準確的行情指引、專業的貨品履約和有保障的售後服務。一畝田「沃來采」的模式類似於已在紐交所上市的「貝殼」，不同的是貝殼屬於房產領域，而一畝田是在農業領域，通過整合數百萬農產品經紀人群體，用「規範服務、真實貨源、售後保障」滿足買家新需求，目前已在中國開出數十家線下門店，並在持續複製擴張中。貝殼市值最高超過600億美元，覆蓋4.6萬家門店、約50萬房產經紀人。農業領域經紀人數量遠大於房產行業，整體的農產品流通市值達數萬億級，抽佣比例上看貝殼約為1%-3%，農產品經紀人佣金通常達到5%甚至更高，且交易頻率遠大於房產，市場前景令人期待。基於互聯網平台沉澱的用戶和數據，「沃來采」農產品經紀業務將有廣闊的發展空間。目前美國資本市場上，來自中國的農業上市企業以傳統的農資、養殖企業為主，一畝田將是唯一一個覆蓋中國農業全產業鏈的農業互聯網企業，這不僅意味著其可以充分享受中國在鄉村全產業發展支持中的政策紅利，更有機會成為創新商業機會的發現和引領者。相信一畝田的上市，將是中國數字農業科技企業在國際舞台的重要亮相，也將為全球投資者參與中國蓬勃壯闊的鄉村振興事業提供前所未有的機會，共享中國農業現代化發展的價值增長。Contact:pr-team@intelligentjoy.com Copyright 2025 亞太商訊 via SeaPRwire.com.

SAN DIEGO, July 23, 2025 - (ACN Newswire via SeaPRwire.com) - Denmark and the NATO Support and Procurement Agency (NSPA) have announced the procurement of four MQ-9B SkyGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. The purchase includes three Certified Ground Control Stations.Stacy A. Cummings, NSPA General Manager (third from left), with GA-ASI representatives (from left to right) Chris Dusseault, David Alexander, Linden Blue, Christophe Fontaine, Aria Mahdion and Bart Roper at the Royal International Air Tattoo (RIAT).Denmark joins a growing list of European countries that have selected MQ-9B for its multi-domain capabilities with exceptionally long range and endurance. The platform provides pole-to-pole satellite control and de-icing capabilities to enable missions in the harsh conditions of the Arctic in support of Denmark and its NATO Allies. Additionally, MQ-9B's in-house-developed Detect and Avoid System aids MQ-9B's ability to fly in unsegregated airspace for domestic civilian operations, making it highly versatile for operations from Denmark.MQ-9B recently became the first large remotely piloted aircraft to obtain a Military Type Certificate (MTC) from the UK's Military Aviation Authority, certifying its safe operation without geographic restrictions, including over populous areas."It's been a very productive year for our MQ-9B platforms," said GA-ASI President David R. Alexander. "First, we earned MTC and now we've added Denmark to the U.K., Belgium, and Poland as MQ-9B customers in Europe. I believe the extensive waters of the North Sea, Norwegian Sea, and Baltic Sea of the Nordic countries make the MQ-9B a very effective tool for national maritime surveillance and security."MQ-9B SkyGuardian is the first and only unmanned system to offer multi-domain Intelligence, Surveillance, Reconnaissance, and Targeting (ISR&T) as an internal payload that can search the ocean's surface and its depths in support of Fleet Operations. MQ-9B can also be fitted with a number of payloads including a maritime surveillance package with a 360-degree maritime radar and/or sonobuoy dispensing pods.This sale was aided and supported by NSPA, which has developed a contractual framework for supporting cooperation amongst its member nations and promoting the proliferation of MQ-9B in Europe. NSPA has added MQ-9B to its portfolio of defense systems to contract on behalf of European nations, with the goal of enhancing interoperability while facilitating training and joint operations."This procurement demonstrates how NSPA enables efficient, effective and responsive multinational acquisitions for advanced, interoperable capabilities. We are proud to support Denmark in this strategic investment for national maritime surveillance and security," said Ms. Stacy A. Cummings, NSPA General Manager.About GA-ASIGeneral Atomics Aeronautical Systems, Inc. is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact InformationGA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc.Related Images Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, July 23, 2025 - (ACN Newswire via SeaPRwire.com) - Yimutian Inc., a leading B2B digital service provider for agricultural products in China, filed a prospectus with the U.S. Securities and Exchange Commission (SEC) on June 9, seeking to list on Nasdaq under the ticker symbol YMT. The offering price range is set at $4.10 to $5.00 per share, and aiming to raise up to $20 million. Chairman Jinhong Deng and his team are currently conducting a roadshow in the U.S., showcasing Yimutian's unique business model and its profound impact on Chinese agriculture, with the listing expected to be completed by the end of July.Founded in 2011, Yimutian has evolved from a basic information service platform into a comprehensive digital agriculture enterprise covering the entire agricultural supply chain. To date, it has served over 56 million users and attracted investments from top-tier firms such as Sequoia Capital, Yunfeng Capital, and DST Global. Today, it stands as the leading agricultural internet company in China.According to its prospectus, Yimutian is the largest agricultural B2B platform in mainland China in terms of monthly active merchants in 2024. Its core business revolves around the Yimutian app, a digital platform connecting supply and demand for agricultural products. The app primarily serves farm-origin brokers, wholesale market buyers, supermarkets, and e-commerce platforms.Agricultural brokers form a key user base for Yimutian a reflection of the unique dynamics of Chinese agriculture. According to the USDA's 2022 Agricultural Census,the U.S. has approximately 1.9 million family farms covering 880 million acres,with an average farm size of 463 acres and sales primarily through direct channels.In stark contrast, China's agricultural landscape is dominated by smallholder farmers: more than 98% of farmers cultivate over 70% of the country's farmland, with per capita arable land standing at just 0.5 acres. This fragmented, non-standardized production system creates a critical role for brokers, who connect farmers and buyers, managing sourcing, preparation, and logistics. Estimates suggest there are approximately 6 million such farm brokers in China.So far, nearly 800,000 of these brokers are already active on the Yimutian platform - a number that continues to grow annually. Many brokers pay for exposure through ads and verification services, generating revenue for the company. Thanks to its stable internet-driven business, Yimutian reported 2024 revenue of RMB 160 million (approximately $22 million).The market potential is immense. According to Frost & Sullivan, China's primary agricultural product circulation reached RMB 5.5 trillion (around $760 billion) in 2024. As new consumption trends such as e-commerce and group buying reshape the market, more brokers are sourcing directly from production areas - creating fresh opportunities for digitized brokerage services.In 2024,to meet the growing demand for professional and standardized brokerage services, Yimutian launched its offline chain store brand 'Wolaicai'. Leveraging 14 years of accumulated buyer channels and market data, the company uses digital tools, the internet,and Al to redesign a more standardized and efficient brokerage process.These stores provide buyers with nationwide sourcing, accurate market insights, professional fulfillment,and reliable after-sales services.Wolaicai's model is reminiscent of Beike (KE Holdings), the NYSE-listed real estate brokerage platform, though focused on agriculture rather than housing. Like Beike, Wolaicai aims to standardize and scale the brokerage industry. Dozens of Wolaicai stores have already opened across China, with more in the pipeline.Beike, at its peak, achieved a market capitalization exceeding $60 billion, serving 46,000 stores and about 500,000 agents. The agricultural brokerage sector dwarfs this in terms of agent numbers and transaction volumes. Farm brokers typically earn commissions of 5% or more - significantly higher than the 1-3% seen in real estate - and transaction frequency is far greater. With its deep digital roots and robust data assets, Wolaicai is positioned to unlock substantial growth in this trillion-dollar market.Currently, Chinese agricultural companies listed in the U.S.are primarily traditional input suppliers or livestock enterprises.Yimutian stands out as the only internet-based company covering China's entire agricultural supply chain. This positions it to fully apitalize onChina's policy support for rural development and to lead in discovering and driving innovative business opportunities.Yimutian's listing marks a significant milestone for Chinese digital agricultural technology companies on the global stage.It offers global investors an unprecedented opportunity to participate in China's booming rural revitalization efforts and share in the value growth of China's agricultural modernization.Contact: pr-team@intelligentjoy.com Copyright 2025 ACN Newswire via SeaPRwire.com.

WEST PALM BEACH, FLA./MIDHURST, U.K., July 23, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official brand of the United States Polo Association (USPA), served as the Official Apparel Partner of the 2025 British Open Polo Championship for the Cowdray Gold Cup, now in its fifth consecutive year of partnership with Cowdray Park Polo Club. For the first time, USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand, and its media subsidiary, Global Polo Entertainment (GPE), will broadcast the Cowdray Gold Cup on ESPN, bringing high-goal British polo to a global sports audience. Check your local listings for airtimes.U.S. Polo Assn. Photo Credit: Margarita Crotto (@margarita.crotto)The 2025 British Open Polo Championship for the Cowdray Gold Cup was hosted at the historic Cowdray Park Polo Club from June 24 to July 20, with over 35,000 sports fans attending the semi-finals and finals. The prestigious tournament concluded with a thrilling final match as La Dolfina/Scone defeated Kazak with a score of 9-8 in front of over 15,000 fans. Making history, La Dolfina/Scone became the first team to win the British Open Polo Championship for the Cowdray Gold Cup as a father-daughter duo, with legendary player Adolfo Cambiaso and his daughter, Mia Cambiaso. La Dolfina/Scone's game started early with a dominant 3-0 first chukker, maintaining control through sharp teamwork and standout defensive plays from Mia Cambiaso despite a spirited push from Kazak and key goals from Nico Pieres. U.S. Polo Assn. had the honor of presenting the Most Valuable Player Award to Mia Cambiaso from La Dolfina/Scone, who delivered an outstanding performance throughout the tournament.U.S. Polo Assn. provided co-branded apparel for all on-site staff and brought immersive activations for event attendees. In collaboration with Brand Machine Group (BMG), U.S. Polo Assn.'s brand partner in the U.K., the brand hosted ticket sweepstakes, divot stomp prizes, cap giveaways, shopping vouchers, and also offered exclusive products sold on-site at a U.S. Polo Assn. pop-up merchandise shop. The global sports brand also donated to Cowdray Park Polo Club's designated charity, Midhurst Palliative Care, accepted by Dr. Alex MacCallum, Chair of Trustees representing Midhurst Palliative Care."U.S. Polo Assn. is proud to support one of the top tournaments in the world and help bring the excitement of the 2025 British Open Polo Championship for the Cowdray Gold Cup to millions of viewers through ESPN for the first time," said J. Michael Prince, President and CEO of USPA Global, which manages and oversees the multi-billion-dollar U.S. Polo Assn. brand. "This broadcast marks a powerful moment for the sport of polo and aligns with our long-term commitment to increasing access and exposure of the sport and our global sports brand in the U.K., one of our fastest-growing markets, around the globe."Sports fans enjoyed watching one of the highest levels of polo competition while experiencing the English charm of Cowdray Park Polo Club. The British Open Polo Championship for the Cowdray Gold Cup is widely regarded as one of the top tournaments in the world, alongside the U.S. Open Polo Championship®, the Argentine Open Polo Championship, the USPA Gold Cup®, and the Queens Cup. The event's high-goal players included some of the top names in the sport of polo, such as Polo Hall of Famer Adolfo Cambiaso, as well as Poroto and Mia Cambiaso, Facundo and Nico Pieres, Mark Tomlison, Tomas Beresford, James Harper, Hugo Taylor, Camilo Castagnola, Hazel Jackson, and Hilario Ulloa, to name a few."In partnership with U.S. Polo Assn., we continue to build authentic connections while elevating the visibility of the iconic Cowdray Park Polo Club on a global scale to sports fans and consumers," said Boo Jalil, CEO of Brand Machine Group, the U.K., Australian/New Zealand, and Polish partner for the U.S. Polo Assn. brand. "Bringing this prestigious tournament to ESPN viewers worldwide marks a major milestone not only for English polo but for the sport as a whole."First played in 1956 on the illustrious Cowdray Estate, boasting 16,500 acres, the Cowdray Gold Cup remains one of the most prestigious high-goal awards in the United Kingdom and globally today. Cowdray Park is recognized as the ‘Home of English Polo,' with its first competitive polo tournament dating back to 1910. Located in the heart of England, Cowdray Park prides itself on its strong heritage of sporting excellence, where top polo players from around the world compete and are part of its history and tradition."Cowdray Park Polo Club is thrilled to have U.S. Polo Assn. as a valued and long-standing partner of the Gold Cup Competition," said Jonathan Russell, CEO of Cowdray Park Polo Club. "The support of U.S. Polo Assn. as the Official Apparel Partner in the top tournament in the U.K. elevates the tournament experience and helps position the Cowdray Gold Cup on the world stage with its first-ever broadcast on ESPN."Photo Credit: Margarita Crotto (@margarita.crotto)Content Credit: @pololineokAbout U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. Historic deals with ESPN in the United States and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, NBA, and MLB, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global and digital growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the USPA and manages the global, multi-billion-dollar U.S. Polo Assn. brand. Through its subsidiary, Global Polo Entertainment (GPE), USPA Global also manages Global Polo TV, which provides sports and lifestyle content. For more sports content, visit globalpolo.com.About Brand Machine Group (BMG)BMG is an international leader in fashion innovation, which has established itself as a vertical manufacturer and global licensing specialist with over four decades of industry experience. Partnering with recognized market leaders, BMG manages a seamless and collaborative process of designing, manufacturing, and delivering quality products while championing the DNA of a diverse portfolio of brands, spanning fashion, sports, outdoor, and homeware, including adult fashion, kidswear, and accessories.BMG's portfolio of brands includes U.S. Polo Assn. Penfield, New Balance Kids, Duchamp, Jack Wills, Flyers American Born, Lee Kids, Peckham Rye, Wrangler Kids, Juicy Couture. BMG reaffirms its commitment to upholding sustainable and ethical business practices by ensuring full transparency throughout its global supply chain, aligning with the ETI Base Code.Visit uspoloassn.co.uk, brandmachinegroup.com, and follow @brandmachinegroup. For appointments, contact sales@brandmachinegroup.com.About Cowdray Park Polo ClubCowdray Park Polo Club is often described as the Jewel in the Crown of Cowdray. For the last century, Cowdray Park has been at the forefront of professional polo in the U.K. and internationally. Competitive polo has been played at Cowdray since 1910, when it was founded as a small country club by the Pearson family, whose passion for the sport has been unwavering. Cowdray hosts the internationally famous British Open Polo Championship for the Cowdray Gold Cup, and polo teams from around the world flock to Cowdray to participate. The Gold Cup is one of the most important events on the British social calendar and attracts the single largest polo audience in the United Kingdom.For more information about polo at Cowdray, please visit www.cowdraypolo.co.uk.Contact InformationStacey KovalskyVP, Global PR & Communicationsskovalsky@uspagl.com+001.561.790.8036Shannon StilsonVP, Sports Marketing and Mediasstilson@uspagl.com+001.561.227.6994Gina DigregorioHead of Marketinggina.digregorio@brandmachinegroup.com+44 (0) 7741 635 984SOURCE: U.S. Polo Assn. Copyright 2025 ACN Newswire via SeaPRwire.com.

Suwon, South Korea, July 24, 2025 - (ACN Newswire via SeaPRwire.com) - Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has inaugurated its new office in Suwon, Korea. The office relocation reflects Avantor’s continued investment in the Asia Pacific region and its commitment to providing a modern, collaborative workspace for associates.The new office space is designed to enhance collaboration, drive innovation and build closer customer relationships. With this relocation, Avantor is better positioned to continue serving the fast-evolving Korean market while advancing its global mission of setting science in motion to create a better world.Company leaders, including Benoit Gourdier, Executive Vice President, Biopharma Production Segment; Christophe Couturier, Executive Vice President, AMEA Region; and Narayana Rao Rapolu, Senior Vice President, Global Bioprocessing Commercial, joined the office opening, underscoring Korea’s strategic importance within Avantor’s global operations.“Establishing our new office in Suwon is a strategic move that strengthens our presence in one of Asia’s most dynamic markets,” said Christophe Couturier, Executive Vice President, AMEA Region. “This space enables our teams to stay closely connected to our customers’ evolving needs and reinforces our ability to deliver tailored solutions that drive meaningful outcomes in the Asia Pacific region.”About AvantorAvantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.Regional Media Contact:Swati ChhabraManager - Corporate Communications, AMEAAvantor+91 9958404334swati.chhabra@avantorsciences.comGlobal Media ContactEric Van ZantenHead - External CommunicationsAvantoreric.vanzanten@avantorsciences.com Copyright 2025 ACN Newswire via SeaPRwire.com.

香港，2025年7月23日 - (亞太商訊 via SeaPRwire.com) - 7月23日，如祺出行在廣州舉行發佈會，宣佈正式啟動「Robotaxi+」戰略，將憑藉平臺的資源聚合優勢和運營服務經驗，面向各地方監管機構、自動駕駛技術公司及其他生態合作方提供一攬子解決方案，共同加速Robotaxi大規模商業化落地。如祺出行啟動「Robotaxi+」戰略，加速Robotaxi大規模商業化落地基於「Robotaxi+」戰略，如祺出行未來5年將Robotaxi運營覆蓋至100個核心城市，與合作夥伴一起構建超萬輛規模的Robotaxi車隊；還將推動10億級投資計劃，建成覆蓋100個核心城市的Robotaxi三級運維網絡，形成可支撐每年10萬輛Robotaxi線下運維的綜合能力。發佈會上，如祺出行還分別與廣汽商貿、廣汽能源，以及來自廣州、杭州等地的4家Robotaxi資產戰略夥伴簽署合作協議，共同在Robotaxi車隊及運維網絡建設等方面開展深度合作。小馬智行廣汽埃安霸王龍Robotaxi、廣汽集團埃安LX Robotaxi、如祺出行廣汽豐田賽那Robotaxi等Robotaxi車型也亮相發佈會。全開放Robotaxi+平臺提供Robotaxi規模化運營一攬子解決方案Robotaxi作為人工智能在出行行業的最大應用場景之一，已成為出行服務領域高確定性趨勢。據高盛2025年5月研究報告預測，中國Robotaxi市場將經歷爆發式增長，至2035年市場規模將達到470億美元，相比2025年增長近700倍，超過25%的共享出行運力將由Robotaxi貢獻。如祺出行CEO蔣華認為，Robotaxi行業要發展，政策和監管得先行「出行服務的未來必然是Robotaxi。」如祺出行CEO蔣華在發佈會上表示，Robotaxi賽道已經進入比拼落地能力階段，「能否實現規模化商業落地，決定玩家們是否有資格在這個賽道走下去。」Robotaxi進入大規模商業化落地階段，規模化運營這一稀缺能力將不可避免地成為行業競爭的焦點，而公共交通治理也必然面臨新的挑戰，能否實現可靠監管下的高效落地，也將決定行業能否在良性軌道上發展。作為首個率先推出有人駕駛網約車與Robotaxi服務商業化混合運營的出行平臺，如祺出行針對行業發展面臨的新課題，再次率先推出「Robotaxi+戰略」，與產業鏈上下游生態合作方在行業拐點到來之際實現共創共贏。「Robotaxi+」戰略的核心是「一個平臺」，即將原有開放性Robotaxi運營科技平臺升級為開放性「Robotaxi+」平臺，繼續發揮出行平臺開放性，面向行業所有符合本地監管標準的Robotaxi開放運營。同時，「Robotaxi+」平臺將聚合優質的產業鏈資源，面向所有Robotaxi商業化參與方提供Robotaxi規模化運營一攬子解決方案，包括Robotaxi資產運營方案、Robotaxi運維方案等，憑藉高效運維、極致控本實現車輛資產效益最大化，並且車輛運營全流程數據透明、監管高效、安全可靠。兩大計劃同步發力三級運維網絡全方位服務Robotaxi規模化運營為加快推進「Robotaxi+」戰略落地，如祺出行同時發佈「星火計劃」和「星河計劃」兩大拓展計劃，將在Robotaxi車隊規模和運營基礎設施建設兩個維度發力，引領Robotaxi大規模商業化破局。如祺出行COO韓鋒表示，如祺出行將面向所有Robotaxi商業化參與方提供規模化運營一攬子解決方案「星火計劃」致力於擴大Robotaxi運營範圍與車隊規模，讓Robotaxi服務大規模用戶群體。如祺出行將依託在大灣區多個地區開展Robotaxi運營上的豐富積累，對外複製輸出全套標準化Robotaxi運營模式，未來5年覆蓋100個核心城市，與合作夥伴一起構建超萬輛規模的Robotaxi車隊。如祺出行正推進與行業主流自動駕駛技術公司的戰略合作，將陸續接入多種最先進的Robotaxi，持續壯大平臺運營的Robotaxi運力規模。同時，如祺出行還將基於自身豐富的運營數據積累及車輛資產管理經驗，從車型選擇、金融方案、運營託管等方面，向生態合作夥伴提供Robotaxi資產一站式運營解決方案，實現全流程閉環，共同打造大規模Robotaxi車隊投向出行服務市場。針對Robotaxi大規模商業化落地對高效運維服務的海量需求，如祺出行的「星河計劃」將在未來5年推動10億級投資計劃，在100個核心城市建設Robotaxi三級運維網絡，包括如祺Robotaxi速應場、如祺Robotaxi維保站、如祺Robotaxi樞紐中心，總量預計達1000個，形成可支撐每年10萬輛Robotaxi線下運維的綜合能力。這也是行業首個聚焦Robotaxi大規模商業化落地的運營基礎設施網絡。其中，如祺Robotaxi速應場是覆蓋城市全域的基礎運維節點，提供充電、應急停車以及簡單清潔等高頻剛需服務；如祺Robotaxi維保站則是車輛的「智能診療中樞」，將構建「檢測-診斷-維修-養護」全鏈條智能服務體系；而作為「全域運營智能大腦」的如祺Robotaxi樞紐中心，主要承擔整合城市級運營調度、大規模停車、傳感器檢測標定、數據存儲、補能、清潔、維修保養等綜合功能。全球首創Robotaxi商業化混合運營Robotaxi訂單量同比增長超480%「任何在押注Robotaxi上舉棋不定、搖擺猶豫的企業很快就會掉隊，而這個很快可能就是短短數年。」在定位如祺出行的未來發展方向時，蔣華強調：「如祺出行要堅定不移地做Robotaxi大規模商業化的破局者與領跑者。」自2019年成立伊始，如祺出行就基於出行平臺運營優勢，圍繞平臺開放、混合運營兩大核心，積極開展Robotaxi商業化運營實踐，成為推動自動駕駛技術商業化的先行者。2022年4月，如祺出行推出全球首個開放性Robotaxi運營科技平臺，搭建了運營監管平臺、車輛管理系統等完善的機制，向所有符合監管標準的Robotaxi車輛開放；同年10月，通過與戰略合作方合作，如祺出行成為全球首個有人駕駛網約車與Robotaxi服務商業化混合運營的出行平臺。截至2025年6月底，如祺出行平臺運營的Robotaxi運力超300輛，服務覆蓋廣州南沙，深圳寶安、南山，以及橫琴粵澳深度合作區，運營站點超4000個，自有車隊安全運營超400萬公里。如祺Robotaxi服務上線三年以來，已成為大灣區居民「家門口的自動駕駛」，融入越來越多用戶的日常生活、工作。以廣州南沙為例，2025年上半年訂單量，同比增長超過480%。聲明：以上預測信息受市場及政策因素影響，可能與實際情況存在差異，存在不確定性。 Copyright 2025 亞太商訊 via SeaPRwire.com.

聖地牙哥，2025年7月23日 - (亞太商訊 via SeaPRwire.com) - 丹麥與北約支援與採購局（NSPA）宣布，將自通用原子航空系統公司（GA-ASI）採購四架 MQ-9B SkyGuardian® 遠程操控飛機（RPA），此次採購還包括三套認證地面控制站。丹麥加入了越來越多選擇 MQ-9B 的歐洲國家行列，該機型具備多領域作戰能力、航程遠、續航時間長。該平台支援極地至極地的衛星控制，並具備除冰功能，使其能在嚴酷的北極環境中執行任務，支援丹麥及其北約盟國。此外，MQ-9B 配備公司自主研發的「探測與規避系統」（Detect and Avoid System），可在非隔離空域中飛行，滿足國內民用飛行需求，使其在丹麥本土的多樣化任務中展現高度靈活性。MQ-9B 最近成為首個獲得英國軍事航空管理局頒發「軍用型號合格證」（MTC）的大型遠程操控飛機，該證書確認其可在無地理限制的條件下安全飛行，包括在人口稠密區域上空。「對我們的 MQ-9B 平台而言，今年是極為豐收的一年。」GA-ASI 總裁大衛·R·亞歷山大（David R. Alexander）表示，「我們首先獲得了 MTC，現在丹麥也加入英國、比利時與波蘭，成為歐洲的 MQ-9B 用戶。我相信，對於北海、挪威海和波羅的海這些廣闊的北歐海域而言，MQ-9B 是進行國家海上監視與安全任務的有效工具。」MQ-9B SkyGuardian 是首個也是唯一一個可在內部搭載多領域情報、監視、偵察與打擊（ISR&T）能力的無人系統，能夠在支援艦隊作戰的情況下偵測海面與水下目標。MQ-9B 還可搭載多種任務酬載，包括具備 360 度覆蓋能力的海上監視雷達和/或聲納浮標投放艙。此次交易獲得了北約支援與採購局（NSPA）的協助與支持。NSPA 已建立一套契約框架，以推動其成員國之間的合作，並促進 MQ-9B 在歐洲的推廣。NSPA 已將 MQ-9B 納入其國防系統組合，可代表歐洲國家簽訂相關契約，旨在提升各國間的互操作性，同時促進訓練與聯合行動的展開。「這一採購專案展現了 NSPA 如何為先進且具互操作性的能力提供高效、有效且具彈性的多國聯合採購支援。我們很自豪能在丹麥進行的國家海上監視與安全戰略性投資中提供支持。」NSPA 總經理史黛西·A·卡明斯（Stacy A. Cummings）表示。關於 GA-ASI通用原子航空系統公司（GA-ASI）是通用原子公司的子公司，致力於設計與製造成熟可靠的遠程駕駛航空系統（RPA）、雷達與電光及相關任務系統，包括 Predator® RPA 系列與 Lynx® 多模式雷達。GA-ASI 累積飛行時數超過 800 萬小時，提供具備長航時與任務能力的航空平台，並整合感測器與數據鏈系統，以實現持續態勢感知。公司亦研發多種感測器控制與圖像分析軟體，提供飛行員訓練與支援服務，並開發超材料天線。更多資訊請參閱：www.ga-asi.com。Avenger、Gray Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 均為通用原子航空系統公司在美國及其他國家/地區註冊的商標。聯絡資訊GA-ASI 媒體聯絡asi-mediarelations@ga-asi.com(858) 524-8101來源：通用原子航空系統公司相關圖片 Copyright 2025 亞太商訊 via SeaPRwire.com.

美國聖地牙哥，2025年7月23日 - (亞太商訊 via SeaPRwire.com) - 冠科生物是一家總部位於美國的全球合同研究組織（CRO），隸屬於JSR生命科學集團及日本JSR株式會社。今日宣佈：其位於聖地牙哥的實驗室正式通過美國臨床實驗室改進修正案（CLIA）認證。榮獲此次認證標誌著冠科生物在臨床級檢測領域邁出關鍵一步，將進一步強化對客戶臨床及轉化藥物研發的全流程支持能力。CLIA 由美國醫療保險和醫療補助服務中心（CMS）監管，為臨床實驗室的操作準確性、結果可靠性及品質體系設立了嚴格的聯邦標準。冠科生物聖地牙哥實驗室通過此項認證，不僅印證其完全符合國際頂尖實驗室規範，更能為客戶提供可直接用於臨床決策與法規申報的高可信度生物標誌物數據，為藥物研發關鍵節點的決策奠定堅實基礎。「榮獲CLIA認證，是我們踐行『提供高品質合規實驗室服務』承諾的關鍵一步，」冠科生物全球生物標誌物平台副總裁Julie Mayer表示，「這將助力我們拓展服務邊界，憑藉合規化檢測能力加速合作夥伴的臨床開發進程與法規審批效率。」通過CLIA認證後，冠科生物現已具備開展人體樣本臨床檢測的資格，這一能力是推動腫瘤學研究向個體化醫療轉化的核心環節。此次認證進一步鞏固了冠科生物在藥物研發全週期中的可靠合作夥伴地位，可滿足從早期研究到後期臨床試驗的專業化項目需求。如需了解冠科生物更多認證資質資訊，敬請造訪公司官網。關於冠科生物冠科生物隸屬於JSR生命科學集團，是一家專注於加速腫瘤及腫瘤免疫領域藥物研發的全球合同研究組織（CRO）。冠科生物與生物技術企業和製藥公司深度合作，提供涵蓋臨床前研究、轉化醫學平台及臨床試驗支持的創新定制化解決方案。憑藉全球規模最大的商業化人源腫瘤異種移植模型（PDX）庫及近1,000種基於Hubrecht類器官技術（HUB）的腫瘤類器官模型，我們能夠為35種癌症適應症的研究提供卓越的科學見解。冠科生物的專業服務體系涵蓋體內、體外、離體及電腦模擬研究，並輔以貫穿藥物開發全流程的先進實驗室服務。此外，我們擁有具備完整臨床病史的液體活檢樣本庫與人體生物樣本庫，顯著提升腫瘤研究的深度與精度。冠科生物在美國、歐洲及亞太地區設有11個頂尖研發中心，所有實驗室均通過美國病理學家協會（CAP）及國際標準化組織（ISO）認證。了解更多：www.crownbio.com Media Inquiries:Crown BioscienceSarah Martin-Tyrrellpr@crownbio.com Copyright 2025 亞太商訊 via SeaPRwire.com.

Vancouver, British Columbia--(ACN Newswire via SeaPRwire.com - July 22, 2025) - Military Metals Corp. (CSE: MILI) (OTCQB: MILIF) (FSE: QN90) (the "Company" or "MILI") reports the analyses of five samples of antimony (stibnite) and gold-rich mineralized material taken from a historical mine stockpile at the Company's 100% owned past producing West Gore antimony-gold project ("West Gore" or "the Project") located in the Province of Nova Scotia, Canada. These samples were collected as part of efforts to characterize the historical deposit to optimize initial exploration methods. These high-grade results support the documented grades of material historically mined between 1914-1917 when West Gore was one of Canada's most significant antimony producers during World War One, to support the allied war effort. These results complement the announcement on July 8, 2025 that the Company had identified new drill targets extending well beyond the area of previous mining, plans to commence a drill program are currently being finalized.Historical Stockpile Sample Highlights:Highest grade sample returned 40.6 percent (%) Antimony and 106.5 Grams Per Tonne (gpt) in sample 247228 (Antimony samples ranged from 2.12% to 40.6%, gold samples ranged from 11.75 gpt to 106.5 gptAdditional high-grade antimony results included 23.5% and 18.1% in samples 247230 and 247232, respectivelyAdditional high-grade gold results included 27.4 gpt and 25.8 gpt in samples 247232 and 247230, respectivelyAverage antimony results over all five samples of 17.94%Average gold results over all five samples of 34.68 gpt3 high priority drill targets that were never previously identified will be drill tested in an upcoming work programScott Eldridge, CEO of Military Metals, stated: "The recent samples collected of up to 40.6% antimony seen in massive stibnite, the mineral that hosts antimony, from our project area have returned some spectacular results, reinforcing our exploration plan to commence drilling. With additional exploration, we can further unlock the potential of our asset and, play a strategic role in the critical minerals supply chain at a time when secure, domestic sources of antimony are in growing demand. Today's results also demonstrate the gold values that could be an important by-product or co-product as we prepare to drill. We are extremely encouraged by the high antimony and gold grades of these five specimens from the past producing mine at our Nova Scotia project. We look forward to advancing this discovery through further exploration and unlocking its full value for our shareholders. Nova Scotia's government, led by Environment Minister Tim Halman, has announced updates to the approval process for metal-mining projects aimed at accelerating timelines. In summary, the new rules are designed to streamline mining approvals and benefit industry progress."Summary of Results:Historical documentation reports that 32,000 metric tons were mined at West Gore in turn producing 7,000 metric tons of concentrate grading 46% antimony yielding 3,220 metric tons of antimony metal, and 6,861 ounces of gold (source: NI 43-101 Technical Report for the West Gore Sb-Au Project, May 25, 2021, prepared by M.S. King, PGeo & M.C. Corey PGeo, May 25, 2021, for Battery Elements Corp). This indicates recovered grades of 10.06% antimony and 0.21 ounces per ton (6.5 gpt) gold, historically. Historical mining was both small-scale and selective, almost certainly enhanced by hand sorting at surface prior to processing. Commercial production ceased in 1917.Table 1 below displays the analytical results for antimony and gold from the five samples. Antimony varies from a low of 2.12 to a high of 40.6%, for an average of 17.94%; gold varies from a low of 11.75 to a high of 106.5 gpt, for an average of 34.68 gpt (uncapped). These grades support the accuracy of historical documentation of mined grades. Of mineralogical interest is the fact that two of the samples, 247230 and 247231, ran 2.01 and 2.81% lead, respectively.Table 1: Sample ResultsTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/259593_6c12fb9e645578af_001full.jpgNote: Grab samples are selective by nature and samples visually estimated to be high-grade were intentionally selected for characterization in this exercise. The results presented in this news release should not be considered overall representative of the historically exploited West Gore deposit or the stockpile from which they were chosen. The historical nature of this stockpile is unknown.Image 1: Sample 247228 Demonstrating Massive StibniteTo view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/10818/259593_6c12fb9e645578af_002full.jpgQuality Assurance and Quality Control:The samples were analyzed at the laboratories of ALS Canada in Vancouver. Samples were crushed, split, ground, split, and a 35 gram portion subjected to a four-acid digestion followed by Induction Coupled Plasma ("ICP") - Mass Spectrometry ("MS") analysis. Over-limit samples for gold and antimony (all five of them) were analyzed by fire assay and ICP- Atomic Emission Spectrometry ("AES") analysis, respectively. Internal Quality Assurance - Quality Control protocols were followed by the lab including blanks, standards, and duplicates to ensure analytical accuracy.Mining History and Geology of the Region:Gold in Nova Scotia was first discovered in 1860, which led to gold rushes throughout many parts of the province over the years following. Gold production in the Rawdon hills began in 1884 and continued until 1932 from several mines. Gold deposits of Nova Scotia's Meguma Terrane typically occur as relatively shallow-dipping, bedding-parallel "saddle reef" type vein systems controlled by regional fold structures. Gold deposits of the Rawdon area, which is found at the east edge of West Gore, are uniquely characterized by the occurrence of steeply east-dipping gold-bearing veins striking north-northwest across bedding. The Government of Nova Scotia's Mineral Occurrence Database reports that historical production from the Rawdon Hills area mines totaled 13,494 ounces. Antimony is a common accessory element in many gold mines around the world, occasionally occurring in higher concentrations.The technical contents of this release were reviewed and approved by David Murray PGeo, President and Principal Consultant of Resourceful Geoscience Solutions Inc. of Halifax, Nova Scotia, a consultant to the Company, and qualified person as defined by National Instrument 43-101. Mr. Murray has independently verified that the historical information presented here about the West Gore deposit is consistent with the historical records available.For more information about Military Metals Corp. and its critical minerals initiatives, please visit: https://www.militarymetalscorp.com.LinkedIn: https://www.linkedin.com/company/military-metals/X: https://x.com/militarymetalsFacebook: https://www.facebook.com/profile.php?id=61564717587797About Military Metals Corp. The Company is a British Columbia-based mineral exploration company that is primarily engaged in the acquisition, exploration and development of mineral properties with a focus on antimony.ON BEHALF OF THE BOARD of DIRECTORSFor more information, please contact:Scott EldridgeCEO and Directorscott@militarymetalscorp.com or info@militarymetalscorp.comFor enquiries, please call 604-537-7556This news release contains "forward-looking information". Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-Looking information in this news release includes statements related to the Company's exploration of the Project, including exploration activities at West Gore such as its anticipated future drill program, and the potential for further activities beyond the exploration stage, or the ability of the Company to be part of the supply chain of either antimony or gold. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Additional risk factors can also be found in the Company's public filings under the Company's SEDAR+ profile at www.sedarplus.ca. Forward-Looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances, management's estimates, or opinions should change, except as required by securities legislation. Accordingly, the reader is cautioned not to place undue reliance on forward-looking statements.The Canadian Securities Exchange has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/259593 Copyright 2025 ACN Newswire via SeaPRwire.com.

- The Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks drew to a successful close today, with an enthusiastic response from booklovers despite the typhoon. Following the adverse weather, the three fairs extended their opening hours, recording 890,000 visits in total- The Eight Seminar Series at the Hong Kong Book Fair was well-received, with renowned writers’ seminars reaching full capacity and drawing active participation from both citizens and tourists- The three mega events successfully attracted a diverse range of visitors, including local people and tourists from Mainland China, while some Book Fair exhibitors even welcomed booklovers from Japan and Southeast AsiaHONG KONG, July 22, 2025 - (ACN Newswire via SeaPRwire.com) - A Hong Kong spotlight event in July and a feature of Hong Kong Summer Viva, the 35th HKTDC Hong Kong Book Fair, 8th HKTDC Sports and Leisure Expo and 5th HKTDC World of Snacks drew to a successful close today. Organised by the Hong Kong Trade Development Council (HKTDC), the three events brought together more than 770 exhibitors, combining the fun of reading, sports, leisure and food to create a summer extravaganza with widespread appeal. Although the passage of the typhoon forced a full-day closure on Sunday, the three exhibitions still attracted 890,000 visits.Sophia Chong, HKTDC Deputy Executive Director, said: “The Hong Kong Book Fair has long been a popular event for local people and visitors alike. The enthusiasm of booklovers remained undiminished despite the typhoon on Sunday. Many seized the time before and after the typhoon to visit and immerse themselves in this cultural and leisure extravaganza, with a robust turnout. We extended the opening hours on Monday, striving to secure more sales and visiting opportunities for exhibitors and visitors and bring this big summer event to a successful close.”Ms Chong added that this year's 35th edition of the Book Fair, themed “Food Culture: Future Living”, featured three special offers that were well received, including free admission for more than 10,000 individuals born in 1990. “These initiatives received an enthusiastic response, with seminars reaching full capacity. Esteemed writers from various regions engaged with booklovers, further cementing Hong Kong’s position as an east-meets-west centre for international cultural exchange,” she said.In conjunction with the Book Fair, the Sports and Leisure Expo and World of Snacks offered a diverse range of experiences and culinary delights, creating synergies for visitors and enhancing the overall event experience. The HKTDC will continue to organise a variety of exhibitions, with the Food Expo, Food Expo PRO, Beauty & Wellness Expo, Home Delights Expo, and Hong Kong International Tea Fair all taking place in August. The overarching goal is to present exhibitors with new business opportunities that can contribute to the sustained growth and vibrancy of the Hong Kong economy.Enthusiasm of booklovers remains high despite typhoonBig crowds of visitors were seen throughout the Book Fair. Exhibitor Creation Cabin Limited, which experienced long queues as soon as the fair opened, followed the Kowloon Walled City craze to launch Citi of Darkness: The Rise within the Walls 1973-1988, attracting many Japanese readers. Editor Shing Kit said: "We saw about 30 to 40 Japanese readers visiting our booth each day. One of them had even made a special effort to renew their passport to travel to Hong Kong to purchase the book at the Book Fair, which is truly touching."First-time exhibitor Anything But also experienced long queues. Booth representative Ms Tai stated that business surpassed expectations, with sales in the first three days exceeding their projections by 30%. Although the typhoon caused a one-day halt, the overall results still beat their estimates. "The Book Fair is a great opportunity for us to connect with readers,” she said. “In addition to local booklovers, many readers travelled to Hong Kong from Macao, Singapore and Malaysia, and one even rescheduled a flight to arrive earlier on Saturday because of the typhoon."An antiquities shop specialising in calligraphy and artworks, Tsi Ku Chai was also participating in the exhibition for the first time, meticulously crafting their booth in the new Cultural and Creative Products Zone of the Book Fair. Brian Lai, Administrative Director of the company, said: "Business on Saturday doubled compared to weekdays, with many young people visiting. We aim to rejuvenate our brand by collaborating with artists to launch cultural and creative products, and the Book Fair served as an excellent testing ground for this."Long-time visitor Ms Lee attended the Book Fair this year before the typhoon hit Hong Kong and was pleased with the atmosphere and arrangements. She mentioned that she couldn’t explore the entire fair in one day, so upon learning about the early opening on Monday, she decided to visit again and continue searching for her favourite items, mainly purchasing stationery and speciality products. She spent nearly HK$2,000 in total this year, which is more than in previous years.Over 50% of Book Fair visitors attended to explore new booksDuring the Book Fair, more than 860 visitors were interviewed by a research institute commissioned by the HKTDC to gain insights into their reading and spending habits. The survey showed that respondents spent an average of HK$918 at this year’s Book Fair, a slight increase compared to last year, and that this spending accounted for 57% of their annual print book expenditure. Over 90% of exhibitors at the three fairs offered an electronic payment service, while 81% of visitors interviewed said they used electronic payments for their transactions. The main objectives for people visiting the Book Fair were given as obtaining newly released books (55%), enjoying discounts (49%) and experiencing the cultural atmosphere of an international book fair (27%). The Book Fair is pivotal as the premier destination for booklovers seeking high-quality reading materials, providing a crucial platform for promotions and sales within the publishing industry. The survey also showed that the most popular book categories among readers this year were fiction and novels (45%), children and youth-related books (25%), literature (23%), comics (17%), and supplementary exercise (16%). Reading enthusiasm sweeps through July with more exciting contentTo further promote reading and culture in Hong Kong, the Book Fair is once again organising Cultural July, featuring multiple cultural activities across the city’s 18 districts. The activity is organised in collaboration with the Leisure and Cultural Services Department of the Hong Kong Special Administrative Region (HKSAR) Government as well as publishers and various educational, cultural and arts institutions. Activities will continue until 31 July – more details can be found athttps://hkbookfair.hktdc.com/CulturalJuly/index.aspx.Recordings of selected Book Fair seminars are available online and can be revisited at any time through the Book Fair website or via other HKTDC online platforms.Visitors enjoy sports, leisure and culinary experiences at concurrent fairsTo support the 15th National Games, the 12th National Games for Persons with Disabilities and the 9th National Special Olympic Games, and to promote wider sports participation among the public, the Sports and Leisure Expo featured an exhibition area where visitors could take photos with games mascots Xiyangyang and Lerongrong. Appealing to individuals of all ages, the expo provided information on the National Games and let visitors try out emerging sports, AI-driven sports and a wellness management platform as well as different sports and leisure products. The FIBA 3x3 World Tour Hong Kong 2025 basketball tournament, held indoors at the HKCEC for the first time, also introduced a carnival-style 3x3 Village that offered visitors a multitude of experiences to enjoy. The World of Snacks gathered over 1,300 different products this year, featuring a variety of global snacks, classic flavours, healthy options and handcrafted snacks, ensuring that visitors left with a full array of treats.Following on from these three successful events, the HKTDC will continue in its mission to organise a diverse range of exhibitions that can actively help Hong Kong entrepreneurs build global connections and advance Hong Kong’s role as a superconnector and super value-adder. August will see the staging of the Food Expo, Food Expo PRO, Beauty & Wellness Expo, Home Delights Expo, and Hong Kong International Tea Fair, while September features the Hong Kong Watch & Clock Fair, Salon de TIME, CENTRESTAGE and the Belt and Road Summit. October will see the Hong Kong Electronics Fair (Autumn Edition), Hong Kong International Lighting Fair (Autumn Edition), electronicAsia, Eco Expo Asia and Hong Kong International Outdoor and Tech Light Expo. Taking place in November will be the Hong Kong International Wine & Spirits Fair and Hong Kong International Optical Fair, while December sees DesignInspire, HKTDC Entrepreneur Day and the Business of IP Asia Forum all taking place in Hong Kong.Photo download: https://bit.ly/4eYhOqmThe Hong Kong Book Fair, Sports and Leisure Expo and World of Snacks drew to a successful close today. The concurrent events attracted 890,000 visits.Paul Chan, Financial Secretary of the HKSAR, interacted with booksellers and citizens at the Book Fair. He also visited the newly established Hong Kong Tech Showcase area and the Cultural and Creative Products Zone, demonstrating his support for the advancement of innovative technology and cultural creativity in Hong Kong.The Eight Seminar Series at the Hong Kong Book Fair fostered engaging interactions between authors and booklovers, attracting numerous locals and tourists to participate. The image shows a lecture by Xu Zi-dong, former Chair of the Department of Chinese at Lingnan University.This year's Book Fair not only received strong support from many Chinese-language authors but also attracted numerous foreign-language authors to speak. The image shows a lecture by Dr Sian “Leo” Proctor.To echo the Book Fair’s theme of the year, “Food Culture-Future Living", the World of Art and Culture, funded by the Cultural and Creative Industries Development Agency of the Government of the Hong Kong Special Administrative Region, featured a cross-cultural exhibition in which eight local and overseas artists collaborated with various Consulates-General in Hong Kong. The exhibition received widespread acclaim from visitors, particularly for its engaging interactive installations which proved very popular.Making its debut at the Sports and Leisure Expo, Gymetaverse Company Limited partners with multiple sport associations to deliver new sporting experiences, promoting AI-driven sports and a wellness management platform.The FIBA 3x3 World Tour Hong Kong 2025 basketball tournament, held indoors at the HKCEC for the first time, also introduced the carnival-style 3x3 Village that offered visitors a multitude of experiences to enjoy.The Travel Zone added a Thailand Pavilion this year, offering an introduction to in-depth travel experiences in Thailand and featuring Thai cultural dance performances for the delight of the public. The World of Snacks gathered over 1,300 different treats, featuring a variety of global snacks, classic flavours, healthy options and handcrafted snacks.Disclaimer: The Government of the Hong Kong Special Administrative Region provides funding support to the project only, and does not otherwise take part in the project. Any opinions, findings, conclusions or recommendations expressed in these materials/events (or by members of the project team) are those of the project organisers only and do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Culture, Sports and Tourism Bureau, the Cultural and Creative Industries Development Agency, the CreateSmart Initiative Secretariat or the CreateSmart Initiative Vetting Committee. Media enquiriesHong Kong Book Fair, Hong Kong Sports and Leisure Expo and World of SnacksYuan Tung Financial Relations:Agnes Yiu Tel: (852) 3428 5690 Email: ayiu@yuantung.com.hkSalina Cheng Tel: (852) 3428 2362 Email: salcheng@yuantung.com.hkHKTDC’s Communications & Public Affairs Department:Snowy Chan Tel: (852) 2584 4525 Email: snowy.sn.chan@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgHong Kong Sports and Leisure Expo, World of SnacksHKTDC’s Communications & Public Affairs Department:Stanley So Tel: (852)2584 4049 Email: stanley.hp.so@hktdc.orgJane Cheung Tel: (852) 2584 4137 Email: jane.mh.cheung@hktdc.orgHKTDC Media Room: http://mediaroom.hktdc.comAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit:www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.